Predictmedix Inc.
PMEDF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.23 | -0.91 | 0.78 |
| FCF Yield | -2.11% | -15.56% | -8.99% | -5.21% |
| EV / EBITDA | -2.22 | -5.62 | -3.94 | -7.13 |
| Quality | ||||
| ROIC | 59.73% | 1,213.40% | 1,787.49% | -189.44% |
| Gross Margin | 0.00% | 0.00% | 76.01% | 76.01% |
| Cash Conversion Ratio | 0.03 | 0.82 | 0.26 | 0.28 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | – | – |
| Free Cash Flow Growth | 97.76% | -142.03% | 0.00% | 65.19% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.02 | 0.02 | 0.10 |
| Interest Coverage | 0.00 | -193.51 | -719.47 | -575.73 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -0.28 |
| Cash Conversion Cycle | 0.00 | -1,228.31 | -36,076.53 | -11,845.59 |